Q2 2017 Holdings
Filed 2017-07-11 | 108 holdings | $50.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Exelixis Inc(EXEL) | COM | 30161Q104 | $25.9K | 1,050,000 | 0.1% |
| Horizon Pharma Plc | SHS | G4617B105 | $28.8K | 2,422,090 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $837.0K | 30,000 | 1.7% |
| Coherus BioSciences Inc(CHRS) | COM | 19249H103 | $2.4M | 168,872 | 4.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.4M | 80,190 | 12.7% |
| AbbVie Inc(ABBV) | COM | 00287Y109 | $9.8M | 135,000 | 19.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $13.2M | 48,500 | 26.1% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $17.2M | 189,300 | 34.1% |